Phase 3 Program on Cobitolimod for UC Discontinued After Inability to Meet Primary Endpoint
The risk of developing an inflammatory bowel disease (IBD) such as Crohn's disease or ulcerative colitis (UC) has been slowly but steadily increasing over time, with an estimated 0.8%…